Calliditas: Orphan drug designation granted by the FDA

Research Note

2019-02-05

12:31

Calliditas announced earlier today that FDA has granted orphan drug designation for the treatment of Autoimmune hepatitis. The news was expected and provide Calliditas with the usual Orphan drug-related advantages.

MS

Mathias Spinnars

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.